{"qas": [{"question": "N\u1ebfu m\u1ed9t ng\u01b0\u1eddi c\u00f3 b\u1ec7nh lao kh\u00e1ng rifampicin v\u00e0 isoniazid, h\u1ecd c\u00f3 lo\u1ea1i b\u1ec7nh n\u00e0o?", "id": "5727b0c23acd2414000de9db", "answers": [{"text": "MDR-TB", "answer_start": 462}], "is_impossible": false}, {"question": "S\u1ed1 l\u01b0\u1ee3ng t\u1ed1i thi\u1ec3u c\u1ee7a c\u00e1c l\u1edbp thu\u1ed1c th\u1ee9 hai m\u00e0 b\u1ec7nh lao c\u1ee7a b\u1ea1n s\u1ebd ph\u1ea3i ch\u1ed1ng l\u1ea1i \u0111\u1ec3 l\u00e0m cho n\u00f3 \u0111\u01b0\u1ee3c t\u00ednh l\u00e0 &quot;kh\u00e1ng thu\u1ed1c r\u1ed9ng r\u00e3i&quot;?", "id": "5727b0c23acd2414000de9dc", "answers": [{"text": "three", "answer_start": 618}], "is_impossible": false}, {"question": "\u1ede n\u01b0\u1edbc n\u00e0o l\u00e0 tr\u01b0\u1eddng h\u1ee3p \u0111\u1ea7u ti\u00ean c\u1ee7a b\u1ec7nh lao kh\u00e1ng thu\u1ed1c ho\u00e0n to\u00e0n?", "id": "5727b0c23acd2414000de9dd", "answers": [{"text": "Italy", "answer_start": 774}], "is_impossible": false}, {"question": "Thu\u1ed1c kh\u00e1ng sinh duy nh\u1ea5t c\u00f3 th\u1ec3 c\u00f3 hi\u1ec7u qu\u1ea3 ch\u1ed1ng l\u1ea1i lao ho\u00e0n to\u00e0n kh\u00e1ng thu\u1ed1c l\u00e0 g\u00ec?", "id": "5727b0c23acd2414000de9de", "answers": [{"text": "Bedaquiline", "answer_start": 860}], "is_impossible": false}, {"question": "C\u00e1c tr\u01b0\u1eddng h\u1ee3p lao kh\u00e1ng thu\u1ed1c ho\u00e0n to\u00e0n \u0111\u00e3 \u0111\u01b0\u1ee3c t\u00ecm th\u1ea5y \u1edf qu\u1ed1c gia n\u00e0o ngo\u00e0i \u00dd v\u00e0 \u1ea4n \u0110\u1ed9?", "id": "5727b0c23acd2414000de9df", "answers": [{"text": "Iran", "answer_start": 844}], "is_impossible": false}, {"plausible_answers": [{"text": "secondary (acquired) resistance", "answer_start": 136}], "question": "M\u1ed9t ng\u01b0\u1eddi kh\u00f4ng d\u1ec5 b\u1ecb MTP ph\u00e1t tri\u1ec3n c\u00e1i g\u00ec?", "id": "5a871d531d3cee001a6a10d8", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "compliance", "answer_start": 273}], "question": "Thu\u1ed1c c\u00f3 ch\u1ea5t l\u01b0\u1ee3ng th\u1ea5p l\u00e0 v\u00ed d\u1ee5 v\u1ec1 s\u1ef1 thi\u1ebfu h\u1ee5t?", "id": "5a871d531d3cee001a6a10d9", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Totally drug-resistant TB", "answer_start": 673}], "question": "\u0110i\u1ec1u g\u00ec \u0111\u00e3 \u0111\u01b0\u1ee3c b\u00e1o c\u00e1o \u0111\u1ea7u ti\u00ean \u1edf Iran?", "id": "5a871d531d3cee001a6a10da", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "2003", "answer_start": 766}], "question": "Khi n\u00e0o th\u00ec MDR-TB \u0111\u01b0\u1ee3c quan s\u00e1t l\u1ea7n \u0111\u1ea7u ti\u00ean?", "id": "5a871d531d3cee001a6a10db", "answers": [], "is_impossible": true}, {"plausible_answers": [{"text": "Italy", "answer_start": 774}], "question": "Bedaquiline \u0111\u01b0\u1ee3c t\u1ea1o ra \u1edf \u0111\u00e2u?", "id": "5a871d531d3cee001a6a10dc", "answers": [], "is_impossible": true}], "context": "Kh\u00e1ng ti\u1ec3u h\u1ecdc x\u1ea3y ra khi m\u1ed9t ng\u01b0\u1eddi b\u1ecb nhi\u1ec5m m\u1ed9t ch\u1ee7ng kh\u00e1ng lao. M\u1ed9t ng\u01b0\u1eddi c\u00f3 \u0111\u1ea7y \u0111\u1ee7 m\u1eabn c\u1ea3m MTB c\u00f3 th\u1ec3 ph\u00e1t tri\u1ec3n <b5_0> kh\u00e1ng th\u1ee9 c\u1ea5p <b5_0/> trong th\u1eddi gian \u0111i\u1ec1u tr\u1ecb v\u00ec \u0111i\u1ec1u tr\u1ecb kh\u00f4ng \u0111\u1ea7y \u0111\u1ee7, kh\u00f4ng d\u00f9ng ch\u1ebf \u0111\u1ed9 quy \u0111\u1ecbnh m\u1ed9t c\u00e1ch th\u00edch h\u1ee3p (thi\u1ebfu <b6_0> s\u1ef1 tu\u00e2n th\u1ee7 <b6_0/> ), ho\u1eb7c s\u1eed d\u1ee5ng thu\u1ed1c c\u00f3 ch\u1ea5t l\u01b0\u1ee3ng th\u1ea5p. Lao kh\u00e1ng thu\u1ed1c l\u00e0 m\u1ed9t v\u1ea5n \u0111\u1ec1 s\u1ee9c kh\u1ecfe c\u1ed9ng \u0111\u1ed3ng nghi\u00eam tr\u1ecdng \u1edf nhi\u1ec1u n\u01b0\u1edbc \u0111ang ph\u00e1t tri\u1ec3n, v\u00ec \u0111i\u1ec1u tr\u1ecb l\u00e2u h\u01a1n v\u00e0 \u0111\u00f2i h\u1ecfi c\u00e1c lo\u1ea1i thu\u1ed1c \u0111\u1eaft ti\u1ec1n h\u01a1n. <a0_0> MDR-TB <a0_0/> \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh l\u00e0 kh\u00e1ng v\u1edbi hai lo\u1ea1i thu\u1ed1c lao \u0111\u1ea7u ti\u00ean hi\u1ec7u qu\u1ea3 nh\u1ea5t: rifampicin v\u00e0 isoniazid. Lao kh\u00e1ng thu\u1ed1c r\u1ed9ng r\u00e3i c\u0169ng kh\u00e1ng v\u1edbi <a1_0> s\u1ed1 ba <a1_0/> ho\u1eb7c nhi\u1ec1u h\u01a1n trong s\u1ed1 s\u00e1u lo\u1ea1i thu\u1ed1c th\u1ee9 hai. <b7_0> Lao kh\u00e1ng thu\u1ed1c ho\u00e0n to\u00e0n <b7_0/> c\u00f3 kh\u1ea3 n\u0103ng ch\u1ed1ng l\u1ea1i t\u1ea5t c\u1ea3 c\u00e1c lo\u1ea1i thu\u1ed1c hi\u1ec7n \u0111ang s\u1eed d\u1ee5ng. N\u00f3 l\u1ea7n \u0111\u1ea7u ti\u00ean \u0111\u01b0\u1ee3c quan s\u00e1t th\u1ea5y trong <b8_0> 2003 <b8_0/> trong <a2_0><b9_0> N\u01b0\u1edbc \u00fd <b9_0/><a2_0/> , nh\u01b0ng kh\u00f4ng \u0111\u01b0\u1ee3c b\u00e1o c\u00e1o r\u1ed9ng r\u00e3i cho \u0111\u1ebfn n\u0103m 2012 v\u00e0 c\u0169ng \u0111\u00e3 \u0111\u01b0\u1ee3c t\u00ecm th\u1ea5y trong <a4_0> Iran <a4_0/> v\u00e0 \u1ea4n \u0110\u1ed9. <a3_0> Bedaquiline <a3_0/> \u0111\u01b0\u1ee3c h\u1ed7 tr\u1ee3 t\u1ea1m th\u1eddi \u0111\u1ec3 s\u1eed d\u1ee5ng trong nhi\u1ec1u lao kh\u00e1ng thu\u1ed1c."}